Drug:
Reaction: MALAISE
20260101 - 20261231
No. 401 - 500
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 401 | 26916726 |
EU |
||
Pneumonia bacterial, Atrial fibrillation, Tinnitus, Bowel movement irregularity, Arthralgia, Brain fog, Pyrexia, Gait disturbance, Malaise, Asthenia, |
||||
ALIROCUMAB, |
||||
| 402 | 26916896 |
US |
63 | 2 |
Infusion site erythema, Malaise, Lethargy, Brain fog, Slow response to stimuli, Fatigue, Infusion site extravasation, Phlebitis, Cellulitis, Dermatitis contact, Headache, |
||||
DONANEMAB-AZBT, |
||||
| 403 | 26917050 |
US |
63 | 1 |
Serotonin syndrome, Haemorrhage, Precancerous condition, Bleeding time abnormal, Insomnia, Feeling abnormal, Feeling of relaxation, Diplopia, Arthralgia, Restless legs syndrome, Feeling hot, Pigmentation disorder, Abnormal dreams, Back pain, Pain, Memory impairment, Thinking abnormal, Anxiety, Aggression, Myalgia, Neck pain, Abdominal distension, Panic attack, Hyperhidrosis, Cold sweat, Dyspnoea, Fatigue, Confusional state, Weight decreased, Night sweats, Burning sensation, Frustration tolerance decreased, Malaise, Chest pain, Chest discomfort, Ligament rupture, Sciatica, Intervertebral disc protrusion, Left ventricular dysfunction, Bronchitis, Body temperature increased, Scratch, Feeling cold, Electrocardiogram abnormal, Aneurysm, Red blood cell count increased, Platelet count increased, Decreased activity, Haematocrit abnormal, Asthenia, Dry skin, Sunburn, Infection, Hypotension, Laboratory test abnormal, Oropharyngeal pain, Limb injury, Condition aggravated, Atrioventricular block, Viral infection, Alopecia, Somnolence, Laryngeal disorder, Pharyngeal disorder, Dysphonia, Drug hypersensitivity, Nausea, Diarrhoea, Dizziness postural, Muscular weakness, General physical health deterioration, Constipation, Weight increased, Blood pressure increased, Contusion, Headache, Flatulence, Product dose omission issue, Drug ineffective, |
||||
AMOXICILLIN, PAROXETINE, PAROXETINE HYDROCHLORIDE, PAROXETINE HYDROCHLORIDE HEMIHYDRATE, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, ALPRAZOLAM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, LISINOPRIL, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, CLOPIDOGREL, CLOPIDOGREL BISULFATE, ROSUVASTATIN, SERTRALINE HYDROCHLORIDE, ERGOCALCIFEROL, |
||||
| 404 | 26917125 |
CA |
40 | 2 |
Fibromyalgia, Memory impairment, Bursitis, Peripheral swelling, C-reactive protein increased, Liver function test increased, Osteoarthritis, Depression, Dyspnoea, Gastrooesophageal reflux disease, Malaise, Glossodynia, Inflammation, Dyspepsia, General physical health deterioration, Irritable bowel syndrome, Swelling, Onychomadesis, Nausea, Injury, Onychomycosis, Muscle spasms, Blood cholesterol increased, Pain, Fall, Folliculitis, Rash, Facet joint syndrome, Maternal exposure during pregnancy, Adverse reaction, Mobility decreased, Abdominal distension, Hand deformity, Ill-defined disorder, Back injury, Hypertension, Confusional state, |
||||
METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ALENDRONATE SODIUM, ALENDRONATE SODIUM, OXYCODONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MEPOLIZUMAB, MEPOLIZUMAB, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LEFLUNOMIDE, LEFLUNOMIDE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, APREMILAST, APREMILAST, NAPROXEN, NAPROXEN SODIUM, MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE, SECUKINUMAB, GOLD, GOLD, CANDESARTAN, MIRABEGRON, MIRABEGRON, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, NICOTINAMIDE, NICOTINAMIDE, |
||||
| 405 | 26917126 |
US |
67 | |
Malaise, Blood pressure increased, Dyspnoea, |
||||
RUXOLITINIB, RUXOLITINIB, |
||||
| 406 | 26917466 |
EU |
39 | 2 |
Gastrointestinal disorder, Dizziness, Hyperhidrosis, Malaise, |
||||
MAVACAMTEN, |
||||
| 407 | 26917714 |
US |
57 | 2 |
Malaise, |
||||
ADALIMUMAB-ADAZ, |
||||
| 408 | 26917866 |
CO |
55 | 2 |
Anal abscess, Constipation, Weight decreased, Malaise, Haemorrhoids, |
||||
LENVATINIB, |
||||
| 409 | 26917928 |
US |
85 | |
Malaise, Therapy interrupted, |
||||
MITOMYCIN, |
||||
| 410 | 26917935 |
CA |
74 | 1 |
Arthralgia, Arthritis, Atrial flutter, Back pain, Blood pressure diastolic decreased, Blood pressure systolic increased, Body temperature increased, Cardiac failure congestive, Concomitant disease aggravated, Diabetes mellitus, Eczema, Fall, Fatigue, Gastrooesophageal reflux disease, Herpes zoster, Hyperhidrosis, Hypotension, Malaise, Mitral valve incompetence, Neck pain, Pain, Peripheral swelling, Photosensitivity reaction, Pneumonia, Pyrexia, Weight decreased, Abdominal pain, Asthenia, Dehydration, Heart rate increased, Cholelithiasis, Pruritus, Rash, Underdose, Injection site mass, Product quality issue, Needle issue, Wrong technique in product usage process, |
||||
ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, BISOPROLOL FUMARATE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, ACETAMINOPHEN AND CODEINE, APIXABAN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, NAPROXEN, NAPROXEN SODIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, TESTOSTERONE, VALSARTAN, VALSARTAN ORAL, |
||||
| 411 | 26917952 |
US |
2 | |
Malaise, |
||||
OFATUMUMAB, |
||||
| 412 | 26918049 |
US |
79 | |
Malaise, Oxygen saturation decreased, Therapy interrupted, |
||||
MITOMYCIN, |
||||
| 413 | 26918168 |
US |
1 | |
Malaise, |
||||
| 414 | 26918174 |
CA |
59 | 2 |
Blood pressure increased, Syncope, Blood iron decreased, Cystitis, Cellulitis, Back pain, Neuralgia, Pain, Hypoaesthesia, Paraesthesia, Diabetes mellitus, Cholelithiasis, Haemorrhage, Hypothyroidism, Endometrial cancer stage I, Second primary malignancy, Nephrolithiasis, Renal impairment, Renal failure, Procedural pain, Carcinoid tumour, Metastases to ovary, Metastases to fallopian tube, Metastases to bladder, Malignant neoplasm progression, Palpitations, Arthralgia, Subcutaneous haematoma, Pain in extremity, Muscle spasms, Peripheral swelling, Serum serotonin increased, Vertigo, Urine output decreased, Myalgia, Contusion, Hepatic pain, Muscle tightness, Groin pain, Nasopharyngitis, White blood cell count increased, Haemoglobin decreased, Urinary tract infection, Acne, Liver function test increased, Hypomenorrhoea, Polyp, Blood urine present, Abdominal adhesions, Endometriosis, Endometrial hyperplasia, Poor quality sleep, Pyrexia, Chills, Cough, Migraine, Anaemia, Blood pressure systolic decreased, Blood pressure diastolic decreased, Joint swelling, Arthritis, Crystal arthropathy, Gout, Joint stiffness, Malaise, Peripheral swelling, Erythema, Joint swelling, Rash pruritic, Asthenia, Heart rate decreased, Vomiting, Dizziness, Abdominal pain, Abdominal tenderness, Rash papular, Diarrhoea, Fatigue, Nausea, Decreased appetite, Injection site mass, Injection site pain, Injection site pain, Injection site reaction, Injection site erythema, Needle issue, |
||||
AMLODIPINE, AMLODIPINE, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CLOPIDOGREL, CLOPIDOGREL BISULFATE, |
||||
| 415 | 26918210 |
US |
82 | |
Blood pressure increased, Nausea, Diarrhoea, Malaise, |
||||
AFICAMTEN, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, RIVAROXABAN, CLOPIDOGREL, |
||||
| 416 | 26918213 |
BR |
56 | 2 |
Dysentery, Lung cancer metastatic, Second primary malignancy, Blood glucose abnormal, Paraesthesia, Skin disorder, Feeding disorder, Arthropathy, Skin exfoliation, Liver disorder, Weight increased, Hypotonia, Weight decreased, Diarrhoea, Dry skin, Rash, Diarrhoea, Mucosal dryness, Aphthous ulcer, Pruritus, Blood glucose increased, Mucosal inflammation, Hepatic enzyme abnormal, Malaise, Nutritional condition abnormal, Liver function test abnormal, Skin discolouration, Glossodynia, Gingival erythema, Bradykinesia, Hypotension, Gastrointestinal disorder, Muscle atrophy, Visual impairment, Memory impairment, Anxiety, Abdominal discomfort, Adverse reaction, Hormone level abnormal, Illness, COVID-19, Dysarthria, Dyspnoea, Blood glucose increased, Erythema, Gingival pain, Fatigue, Abdominal pain upper, Myalgia, Arthralgia, Lung disorder, Posture abnormal, |
||||
FULVESTRANT, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ALPELISIB, ALPELISIB, ALPELISIB, ALPELISIB, ALPELISIB, ALPELISIB, ALPELISIB, ALPELISIB, ALPELISIB, ALPELISIB, ALPELISIB, ALPELISIB, ALPELISIB, ALPELISIB, ALPELISIB, |
||||
| 417 | 26918223 |
CA |
43 | 2 |
Breast cancer stage II, Asthenia, Dislocation of vertebra, Arthralgia, Gait inability, Malaise, Fluid retention, Rheumatoid factor positive, Urticaria, Joint swelling, Synovitis, Asthma, Hand deformity, Mobility decreased, Decreased appetite, Systemic lupus erythematosus, Wound, Rheumatoid arthritis, Lower limb fracture, Injury, Drug hypersensitivity, Road traffic accident, Musculoskeletal pain, Pemphigus, Blood cholesterol increased, Sciatica, Drug intolerance, Liver disorder, |
||||
DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, LEFLUNOMIDE, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, OXYCODONE HYDROCHLORIDE, OXYCODONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ERENUMAB-AOOE, ERENUMAB-AOOE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, SECUKINUMAB, DICLOXACILLIN SODIUM, DICLOXACILLIN SODIUM, DICLOXACILLIN SODIUM, OXYCODONE, OXYCODONE, |
||||
| 418 | 26918316 |
JP |
2 | |
Subclavian artery dissection, Platelet count decreased, Malaise, |
||||
LENVATINIB, |
||||
| 419 | 26918330 |
US |
46 | |
Malaise, Diarrhoea, |
||||
| 420 | 26918589 |
CA |
1 | |
Crohn^s disease, Therapeutic response shortened, Drug ineffective, Malaise, |
||||
USTEKINUMAB-AUUB, |
||||
| 421 | 26918592 |
US |
70 | 1 |
Transfusion, Mental impairment, Malaise, |
||||
TRIFLURIDINE AND TIPIRACIL, |
||||
| 422 | 26918601 |
US |
2 | |
Pharyngitis streptococcal, Malaise, |
||||
INSULIN DEGLUDEC, |
||||
| 423 | 26918613 |
GB |
67 | 1 |
Gastrooesophageal reflux disease, General physical health deterioration, Depression, Mental disorder, Middle insomnia, Malaise, Drug interaction, |
||||
CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, |
||||
| 424 | 26918683 |
US |
1 | |
Malaise, Therapy interrupted, Product physical issue, |
||||
ICOSAPENT ETHYL, |
||||
| 425 | 26918933 |
US |
97 | 2 |
Syncope, Malaise, Dizziness, Urinary tract infection, Dehydration, |
||||
DUPILUMAB, |
||||
| 426 | 26918973 |
US |
||
Malaise, General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 427 | 26918991 |
EU |
45 | 2 |
Toxicity to various agents, Drug ineffective, Off label use, Dizziness, Malaise, Off label use, |
||||
ONABOTULINUMTOXINA, BOTULINUM TOXIN TYPE A, BOTULINUM TOXIN TYPE A, BOTULINUM TOXIN TYPE A, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 428 | 26919015 |
US |
95 | 2 |
Macular degeneration, Malaise, |
||||
| 429 | 26919212 |
US |
90 | 2 |
Ocular discomfort, Malaise, Eye irritation, |
||||
ACOLTREMON, ZOLPIDEM TARTRATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ROSUVASTATIN, MOMETASONE FUROATE AND FORMOTEROL FUMARATE DIHYDRATE, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE HYDROCHLORIDE ORAL, FUROSEMIDE, LATANOPROST, LISINOPRIL, FAMOTIDINE, CYCLOSPORINE, SODIUM BICARBONATE, SODIUM BICARBONATE, INJECTION, SODIUM BICARBONATE INJECTION,, LEVOTHYROXINE SODIUM, METOPROLOL SUCCINATE, CETIRIZINE HYDROCHLORIDE, |
||||
| 430 | 26919929 |
US |
83 | 1 |
Small cell lung cancer, Pain, Malaise, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 431 | 26920045 |
US |
77 | 2 |
Palpitations, Vision blurred, Malaise, Eye irritation, |
||||
ACOLTREMON, ALPRAZOLAM, CALCIUM, DICYCLOMINE HYDROCHLORIDE, PENTOSAN POLYSULFATE SODIUM, FAMOTIDINE, GABAPENTIN, VIBEGRON, PEPPERMINT OIL, MAGNESIUM, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, PROPRANOLOL HYDROCHLORIDE, ERGOCALCIFEROL, |
||||
| 432 | 26920195 |
US |
1 | |
Laryngitis, Chest discomfort, Nausea, Vomiting, Malaise, Off label use, |
||||
PEGLOTICASE, PEGLOTICASE, |
||||
| 433 | 26920454 |
US |
75 | 2 |
Nausea, Dizziness, Malaise, Eye pain, |
||||
ACOLTREMON, CALCIUM, GABAPENTIN, GUAIFENESIN, IRON, MONTELUKAST, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, POLYETHYLENE GLYCOL, CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN, TERIPARATIDE, ACETAMINOPHEN, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, |
||||
| 434 | 26920471 |
US |
2 | |
Malaise, |
||||
TIRZEPATIDE, |
||||
| 435 | 26920759 |
EU |
1 | |
Pituitary tumour, Stress, Cortisol increased, Malaise, |
||||
BIMEKIZUMAB, |
||||
| 436 | 26920953 |
US |
1 | |
Constipation, Malaise, Rash, |
||||
| 437 | 26921041 |
21 | 1 | |
Ejection fraction decreased, Fatigue, Malaise, Myocarditis, Neck pain, Pericarditis, Rhinorrhoea, |
||||
CLOZAPINE, OLANZAPINE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 438 | 26921259 |
US |
2 | |
Malaise, |
||||
TIRZEPATIDE, |
||||
| 439 | 26925594 |
54 | 2 | |
Pneumonia, Malaise, Therapy interrupted, |
||||
VENETOCLAX, |
||||
| 440 | 26909561 |
CL |
66 | 1 |
Gallbladder disorder, Malaise, |
||||
SECUKINUMAB, |
||||
| 441 | 26909591 |
US |
2 | |
Ocular hyperaemia, Feeling hot, Malaise, Feeling abnormal, |
||||
DONANEMAB-AZBT, DONANEMAB-AZBT, DONANEMAB-AZBT, |
||||
| 442 | 26909614 |
CA |
66 | 1 |
Rhabdomyolysis, Paranoia, Infection, Psychotic disorder, Hallucination, tactile, Malaise, Dystonia, Feeling abnormal, Gait inability, Asthenia, |
||||
FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, CARBIDOPA AND LEVODOPA, CLONAZEPAM, |
||||
| 443 | 26909616 |
US |
45 | 2 |
Hepatic cancer metastatic, Malaise, Hepatic infection, |
||||
PANCRELIPASE, |
||||
| 444 | 26909672 |
US |
18 | |
Malaise, |
||||
BUROSUMAB, BUROSUMAB, |
||||
| 445 | 26909760 |
US |
55 | 2 |
Muscle twitching, Migraine, Alopecia, Malaise, Vertigo, |
||||
GALCANEZUMAB-GNLM, ATOGEPANT, |
||||
| 446 | 26909848 |
CA |
64 | 1 |
Eyelid ptosis, Sneezing, Eye pruritus, Insomnia, Diarrhoea, Fall, Head injury, Haemorrhage, Skin laceration, Malaise, Pain in extremity, Abnormal dreams, |
||||
GUSELKUMAB, GUSELKUMAB, |
||||
| 447 | 26909868 |
CA |
40 | 2 |
Drug-induced liver injury, Wound infection, Infusion related reaction, Osteoarthritis, Gait inability, Type 2 diabetes mellitus, Adverse reaction, Abdominal pain upper, Nausea, Asthenia, Dizziness, Neck pain, Underdose, Coeliac disease, Joint swelling, Obesity, Hypersensitivity, Hypertension, Folliculitis, Facet joint syndrome, Lung disorder, Psoriatic arthropathy, Grip strength decreased, Muscular weakness, Swelling, Rheumatoid arthritis, Malaise, Confusional state, Drug hypersensitivity, Insomnia, Liver function test increased, Treatment failure, Arthropathy, Night sweats, Blister, Breast cancer stage III, Gastrooesophageal reflux disease, Drug intolerance, Depression, Rash, Blood cholesterol increased, Hepatitis, Gastrointestinal disorder, Contusion, Weight increased, Injection site reaction, Hand deformity, Dyspepsia, Glossodynia, Joint range of motion decreased, Muscle spasms, Musculoskeletal stiffness, Fatigue, Vomiting, Wound, Helicobacter infection, Drug ineffective, Exposure during pregnancy, Maternal exposure during pregnancy, Intentional product use issue, Off label use, |
||||
ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, CANDESARTAN, CANDESARTAN, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, ERENUMAB-AOOE, |
||||
| 448 | 26909957 |
US |
56 | 2 |
Malaise, Injection site mass, |
||||
GLATIRAMER ACETATE, ERGOCALCIFEROL, |
||||
| 449 | 26909973 |
CA |
69 | 2 |
Anxiety, Blood pressure decreased, Hospitalisation, Loss of personal independence in daily activities, Malaise, Periarthritis, Product dose omission issue, |
||||
HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, AMLODIPINE, AMLODIPINE BESYLATE, BISOPROLOL FUMARATE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, MONTELUKAST, OXYBUTYNIN CHLORIDE, LANSOPRAZOLE, DENOSUMAB, RIVASTIGMINE TARTRATE, TIOTROPIUM BROMIDE, LEVOTHYROXINE SODIUM, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VITAMIN C, FLUTICASONE PROPIONATE, |
||||
| 450 | 26910004 |
US |
66 | 2 |
Dizziness, Malaise, |
||||
DONANEMAB-AZBT, DONANEMAB-AZBT, THYROID, PORCINE, LISINOPRIL, HYDROCHLOROTHIAZIDE, MOMETASONE FUROATE, |
||||
| 451 | 26910091 |
US |
76 | 2 |
Localised infection, Malaise, Influenza, |
||||
DUPILUMAB, |
||||
| 452 | 26910130 |
CA |
2 | |
Cerebrovascular accident, Fall, Cerebrovascular accident, Pneumonia, Fall, Hypovolaemia, Peripheral swelling, Malaise, Diarrhoea, Abdominal discomfort, Fatigue, Arthropod bite, Joint swelling, Erythema, Nausea, Hypertension, Wrist fracture, Rib fracture, Head injury, Suicide attempt, Bronchitis, Productive cough, Unresponsive to stimuli, Malignant neoplasm progression, Suicidal ideation, Vasculitis, Depression, Depressed mood, Nervousness, Nervousness, Psychiatric symptom, Blood pressure increased, Depression, Tremor, Feeling jittery, Pain in extremity, Wound, Cough, Muscular weakness, Pollakiuria, Nasopharyngitis, Gait disturbance, Hypoacusis, Nervousness, Screaming, Contusion, Emotional distress, Anger, Crying, Mental disorder, Anxiety, Headache, Rash, Feeling abnormal, Inappropriate schedule of product administration, |
||||
AMLODIPINE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, GABAPENTIN, OLANZAPINE, PRUCALOPRIDE SUCCINATE, PREDNISONE, ERGOCALCIFEROL, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, CALCIUM CARBONATE, ANTACID, PANTOPRAZOLE, |
||||
| 453 | 26910203 |
EU |
29 | 1 |
Post-injection delirium sedation syndrome, Malaise, Fatigue, Dizziness, Clumsiness, |
||||
OLANZAPINE, |
||||
| 454 | 26910233 |
GB |
73 | |
Diabetes mellitus, Feeling abnormal, Malaise, |
||||
ALIROCUMAB, |
||||
| 455 | 26910237 |
BR |
2 | |
Suicide attempt, Suicidal ideation, Asthenia, Pain, Feeling abnormal, Headache, Wound, Pruritus, Asphyxia, Neoplasm, Tumour pain, Apathy, Syncope, Swelling, Renal impairment, Cardiac arrest, Eye disorder, Cardiac arrest, Coronavirus infection, Pneumonia, Neoplasm malignant, Cardiomegaly, Neoplasm malignant, Pancreatic enlargement, Abnormal organ growth, Metastatic carcinoid tumour, Throat cancer, Metastasis, Metastasis, Disease recurrence, Metastases to bone, Diabetes mellitus, Arrhythmia, Acromegaly, Bone pain, Visual impairment, Bone marrow infiltration, Nervousness, Malaise, Cataract, Mass, Lung disorder, Bone disorder, Back pain, Agitation, Insomnia, Panic reaction, Feeding disorder, Fear, Fatigue, Stress, Skin hypertrophy, Skin discolouration, Balance disorder, General physical condition abnormal, Hepatomegaly, Crying, Mood altered, Endocrine disorder, Deformity, Dyskinesia, Fall, Foot deformity, Dysphonia, Needle issue, Productive cough, Dyspnoea, Influenza like illness, Headache, Oropharyngeal pain, Incorrect dose administered, Product quality issue, Product storage error, Product physical issue, Inappropriate schedule of product administration, Muscular weakness, Myalgia, Coating in mouth, Hormone level abnormal, Therapeutic product effect delayed, Dyspnoea, Cardiac disorder, Tongue disorder, Liver disorder, Pancreatic disorder, Gallbladder disorder, Headache, Vomiting, Injection site pain, Decreased appetite, Bacteroides test positive, Head injury, Malaise, Retching, Cyanosis, Cardiac valve disease, Asthenia, Sluggishness, Platelet count decreased, Decreased immune responsiveness, Haemangioma of bone, Neuralgia, Anxiety, Gait disturbance, Malaise, Pyrexia, Yellow skin, Skin discolouration, Gait disturbance, Laziness, |
||||
OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, SERTRALINE, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, |
||||
| 456 | 26910391 |
CA |
75 | 2 |
Malaise, Cardiac failure, Pneumonia, Thrombosis, |
||||
PREDNISONE, HYDROXYCHLOROQUINE, |
||||
| 457 | 26910405 |
CA |
43 | 2 |
Retinitis, Lung disorder, Joint swelling, Irritable bowel syndrome, Memory impairment, Muscle spasms, Epilepsy, Infusion site reaction, Intentional product use issue, Lip dry, Liver function test increased, Lower respiratory tract infection, Malaise, Type 2 diabetes mellitus, Wheezing, |
||||
ERENUMAB-AOOE, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, OXYCODONE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, CANDESARTAN, CANDESARTAN, CANDESARTAN, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, OXYCODONE HYDROCHLORIDE, OXYCODONE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, |
||||
| 458 | 26910432 |
US |
2 | |
Influenza like illness, Abdominal pain, Nausea, Drug hypersensitivity, Malaise, Feeling abnormal, |
||||
BUPRENORPHINE AND NALOXONE, BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE, |
||||
| 459 | 26910443 |
BR |
64 | 2 |
Pancreatitis acute, Abdominal pain upper, Transient ischaemic attack, Psoriasis, Psoriatic arthropathy, Pyrexia, Malaise, Panic disorder, Anxiety, Cellulitis, Hyperhidrosis, Dizziness, Malaise, Tremor, Dyspnoea, Illness, Dizziness, Uterine cervix atrophy, Drug hypersensitivity, Rebound psoriasis, Skin plaque, Liver disorder, Blood pressure abnormal, Memory impairment, Ischaemia, Feeling abnormal, Feeling hot, Tremor, Vomiting, Depressed mood, Teeth brittle, Swelling, Rash erythematous, Skin sensitisation, Fall, Head injury, Oedema, Back disorder, Fatigue, Fibromyalgia, Intervertebral disc degeneration, Scar, Toothache, Abdominal pain upper, Infection, Reflux gastritis, Arthralgia, Muscle spasms, Fear, Pain in extremity, Pain, Emotional distress, Tooth infection, Drug ineffective, Product availability issue, Product dose omission issue, |
||||
ANASTROZOLE, ANASTROZOLE TABLETS, ANASTROZOLE, ANASTROZOLE TABLETS, ANASTROZOLE, ANASTROZOLE TABLETS, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, ACITRETIN, CALCIUM, LOSARTAN, SIMVASTATIN, AMITRIPTYLINE HYDROCHLORIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 460 | 26910521 |
CA |
59 | 2 |
Blood pressure increased, Syncope, Blood iron decreased, Cystitis, Cellulitis, Back pain, Neuralgia, Pain, Hypoaesthesia, Paraesthesia, Diabetes mellitus, Cholelithiasis, Haemorrhage, Hypothyroidism, Endometrial cancer stage I, Second primary malignancy, Nephrolithiasis, Renal impairment, Renal failure, Procedural pain, Carcinoid tumour, Metastases to ovary, Metastases to fallopian tube, Metastases to bladder, Malignant neoplasm progression, Palpitations, Arthralgia, Subcutaneous haematoma, Pain in extremity, Muscle spasms, Peripheral swelling, Serum serotonin increased, Vertigo, Urine output decreased, Myalgia, Contusion, Hepatic pain, Muscle tightness, Groin pain, Nasopharyngitis, White blood cell count increased, Haemoglobin decreased, Urinary tract infection, Acne, Liver function test increased, Hypomenorrhoea, Polyp, Blood urine present, Abdominal adhesions, Endometriosis, Endometrial hyperplasia, Poor quality sleep, Pyrexia, Chills, Cough, Migraine, Anaemia, Blood pressure systolic decreased, Blood pressure diastolic decreased, Joint swelling, Arthritis, Crystal arthropathy, Gout, Joint stiffness, Malaise, Peripheral swelling, Erythema, Joint swelling, Rash pruritic, Asthenia, Heart rate decreased, Vomiting, Dizziness, Abdominal pain, Abdominal tenderness, Rash papular, Diarrhoea, Fatigue, Nausea, Decreased appetite, Injection site mass, Injection site pain, Injection site pain, Injection site reaction, Injection site erythema, Needle issue, |
||||
OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, AMLODIPINE, AMLODIPINE, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CLOPIDOGREL, CLOPIDOGREL BISULFATE, |
||||
| 461 | 26910658 |
2 | ||
Malaise, |
||||
AMBRISENTAN, TADALAFIL, PREDNISONE, ERGOCALCIFEROL, |
||||
| 462 | 26910744 |
US |
2 | |
Rash, Urticaria, Pruritus, Headache, Malaise, |
||||
LIOTHYRONINE SODIUM, |
||||
| 463 | 26910860 |
US |
||
Autoimmune hepatitis, Hepatitis alcoholic, Malaise, Liver function test increased, |
||||
RESMETIROM, |
||||
| 464 | 26910886 |
CA |
82 | 2 |
Hospitalisation, Dyspnoea exertional, Oedema peripheral, Fall, Pain, Back pain, Dry skin, Malaise, Weight increased, Oedema peripheral, Oedema peripheral, Feeling hot, Cough, Fatigue, Musculoskeletal chest pain, Infusion site oedema, Dyspnoea exertional, Oedema peripheral, Weight increased, Infusion site oedema, Weight decreased, Dyspnoea, Wrong technique in product usage process, Oedema peripheral, Diarrhoea, Oedema peripheral, Dry skin, Oxygen saturation decreased, |
||||
PREDNISONE, MIRTAZAPINE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, LEVOTHYROXINE SODIUM, TEMAZEPAM, IRON, HYDROXYCHLOROQUINE, LEFLUNOMIDE, ERGOCALCIFEROL, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, CALCIUM, SPIRONOLACTONE, |
||||
| 465 | 26910930 |
GB |
2 | |
Lower respiratory tract infection, Injection site erythema, Influenza like illness, Vomiting, Asthenia, Illness, Influenza, Chest discomfort, Feeling abnormal, Influenza like illness, Nausea, Palpitations, Malaise, Pyrexia, Influenza, Dizziness, Asthenia, Pain, Chest discomfort, Weight decreased, Paraesthesia, Ocular discomfort, Head discomfort, Urinary tract infection, Influenza like illness, Nausea, |
||||
OFATUMUMAB, OFATUMUMAB, |
||||
| 466 | 26910941 |
EU |
50 | 2 |
Malaise, Abdominal pain upper, Vomiting, |
||||
CELECOXIB, |
||||
| 467 | 26910943 |
US |
26 | 1 |
Blindness, Hyperhidrosis, Haematochezia, Pallor, Nausea, Visual impairment, Oropharyngeal pain, Malaise, Nocturia, Dizziness, Feeling abnormal, Hyperhidrosis, Suture insertion, Dizziness, Deafness, Dizziness, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
| 468 | 26910986 |
IN |
76 | 2 |
Off label use, Lymphadenopathy, Malaise, Seizure, |
||||
PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF, PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF, |
||||
| 469 | 26911195 |
US |
68 | 2 |
Malaise, |
||||
PANCRELIPASE, |
||||
| 470 | 26911324 |
GB |
1 | |
Swelling face, Decreased appetite, Malaise, |
||||
PIRFENIDONE, |
||||
| 471 | 26911344 |
JP |
2 | |
Thrombosis, Malaise, Decreased appetite, |
||||
NIRAPARIB, EDOXABAN TOSYLATE, |
||||
| 472 | 26911468 |
CA |
43 | 2 |
Rheumatic fever, Malaise, Swollen joint count increased, Road traffic accident, Prescribed overdose, Migraine, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, RISEDRONATE SODIUM, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, LEFLUNOMIDE, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, PREGABALIN, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, TRIMETHOPRIM, APREMILAST, APREMILAST, VITAMIN C, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, SECUKINUMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, CERTOLIZUMAB PEGOL, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, GOLIMUMAB, GOLIMUMAB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, INFLIXIMAB, CALCIUM CARBONATE, CALCIUM CARBONATE, CALCIUM CARBONATE, CALCIUM CARBONATE, CALCIUM CARBONATE, CALCIUM CARBONATE, CALCIUM CARBONATE, CALCIUM CARBONATE, CALCIUM CARBONATE, CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE, CHLORHEXIDINE GLUCONATE, CHLORHEXIDINE GLUCONATE, CHLORHEXIDINE GLUCONATE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, SULFASALAZINE, TOCILIZUMAB, TOCILIZUMAB, TOFACITINIB CITRATE, TOFACITINIB CITRATE, TOFACITINIB CITRATE, TOFACITINIB CITRATE, TOFACITINIB CITRATE, TOFACITINIB CITRATE, TOFACITINIB CITRATE, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, ERGOCALCIFEROL, ERGOCALCIFEROL, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, |
||||
| 473 | 26911492 |
EU |
26 | 2 |
Victim of crime, Amnesia, Malaise, |
||||
SERTRALINE, ALCOHOL, ETHYL ALCOHOL, ISOPROPYL ALCOHOL, |
||||
| 474 | 26911585 |
CA |
65 | 2 |
Wheezing, Asthma, Chest pain, Cough, Drug hypersensitivity, Dyspnoea, Malaise, Nasal oedema, Oedema, Pain, Pneumonia, Respiratory tract infection, Vomiting, |
||||
ROPIVACAINE HYDROCHLORIDE, AMLODIPINE BESYLATE, AMLODIPINE BESYLATE, MONTELUKAST SODIUM, MONTELUKAST, MONTELUKAST SODIUM, MONTELUKAST, RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, AMINOPHYLLINE, BECLOMETHASONE DIPROPIONATE, CALCIUM CARBONATE, ANTACID, CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE, ROSUVASTATIN, ROSUVASTATIN, ROSUVASTATIN, ERGOCALCIFEROL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE, FOLIC ACID, HYDROMORPHONE HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, OMALIZUMAB, OMALIZUMAB, PREDNISONE, RISEDRONATE SODIUM, RISEDRONATE SODIUM, THEOPHYLLINE, THEOPHYLLINE ANHYDROUS, TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE, CEFADROXIL, CEFADROXIL, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, |
||||
| 475 | 26911688 |
US |
2 | |
Extra dose administered, Malaise, |
||||
TIRZEPATIDE, |
||||
| 476 | 26911885 |
US |
2 | |
Influenza like illness, Illness, Malaise, |
||||
BENRALIZUMAB, BENRALIZUMAB, BENRALIZUMAB, BENRALIZUMAB, |
||||
| 477 | 26911919 |
CA |
59 | 2 |
Blood pressure increased, Syncope, Blood iron decreased, Cystitis, Cellulitis, Back pain, Neuralgia, Pain, Hypoaesthesia, Paraesthesia, Diabetes mellitus, Cholelithiasis, Haemorrhage, Hypothyroidism, Endometrial cancer stage I, Second primary malignancy, Nephrolithiasis, Renal impairment, Renal failure, Procedural pain, Carcinoid tumour, Metastases to ovary, Metastases to fallopian tube, Metastases to bladder, Malignant neoplasm progression, Palpitations, Arthralgia, Subcutaneous haematoma, Pain in extremity, Muscle spasms, Peripheral swelling, Serum serotonin increased, Vertigo, Urine output decreased, Myalgia, Contusion, Hepatic pain, Muscle tightness, Groin pain, Nasopharyngitis, White blood cell count increased, Haemoglobin decreased, Urinary tract infection, Acne, Liver function test increased, Hypomenorrhoea, Polyp, Blood urine present, Abdominal adhesions, Endometriosis, Endometrial hyperplasia, Poor quality sleep, Pyrexia, Chills, Cough, Migraine, Anaemia, Blood pressure systolic decreased, Blood pressure diastolic decreased, Joint swelling, Arthritis, Crystal arthropathy, Gout, Joint stiffness, Malaise, Peripheral swelling, Erythema, Joint swelling, Rash pruritic, Asthenia, Heart rate decreased, Vomiting, Dizziness, Abdominal pain, Abdominal tenderness, Rash papular, Diarrhoea, Fatigue, Nausea, Decreased appetite, Injection site mass, Injection site pain, Injection site pain, Injection site reaction, Injection site erythema, Needle issue, |
||||
AMLODIPINE, AMLODIPINE, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CLOPIDOGREL, CLOPIDOGREL BISULFATE, |
||||
| 478 | 26912025 |
US |
52 | 2 |
Drug ineffective, Back pain, Malaise, |
||||
INFLIXIMAB, INFLIXIMAB, TOFACITINIB, LOSARTAN POTASSIUM, LOSARTAN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 479 | 26912101 |
CA |
66 | 2 |
Terminal state, Nausea, Decreased appetite, Cough, Malaise, Diarrhoea, Diverticulitis, Influenza, Alopecia, Disease progression, Dyspnoea exertional, Weight gain poor, Taste disorder, Fatigue, Hypersomnia, Oxygen saturation abnormal, |
||||
NINTEDANIB, NINTEDANIB, |
||||
| 480 | 26912309 |
EU |
62 | 1 |
Circulatory collapse, Renal failure, Metabolic acidosis, Cardiac arrest, Dyspnoea, Malaise, Product prescribing error, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 481 | 26912411 |
UY |
46 | 1 |
Lung disorder, Pneumonitis, Pain in extremity, Product lot number issue, Malaise, |
||||
UPADACITINIB, |
||||
| 482 | 26912422 |
51 | 2 | |
Mycobacterium avium complex infection, Malaise, Drug ineffective, |
||||
AMIKACIN, RIFAMPIN, ETHAMBUTOL HYDROCHLORIDE, CLARITHROMYCIN, |
||||
| 483 | 26912532 |
US |
78 | |
Malaise, Abdominal discomfort, Decreased appetite, Abnormal loss of weight, Weight decreased, |
||||
ORAL SEMAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 484 | 26912542 |
BR |
2 | |
White blood cell count decreased, Abdominal pain, Viral infection, Diarrhoea, Leukopenia, Metastasis, Head discomfort, Reaction to excipient, Blood pressure abnormal, Anxiety, Nail discomfort, Constipation, Decreased immune responsiveness, Abdominal discomfort, Platelet count decreased, Flatulence, Tension, Laziness, Blood test, Illness, Patient-device incompatibility, Nervousness, Insomnia, Lymphoedema, Platelet count abnormal, Malaise, Pain, Abdominal distension, Abdominal discomfort, Gastrointestinal pain, Nausea, White blood cell count decreased, Pyrexia, Fatigue, Abdominal pain upper, Alopecia, Platelet count decreased, Headache, Nausea, Headache, Pain in extremity, Abdominal pain, Pain, Vomiting, |
||||
FULVESTRANT, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, CITALOPRAM, CITALOPRAM HYDROBROMIDE, FULVESTRANT, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 485 | 26912587 |
CA |
69 | 2 |
Blood pressure increased, Dyspnoea, Joint swelling, Tooth infection, Nasopharyngitis, Loss of therapeutic response, Anxiety, Inflammation, Malaise, Product ineffective for unapproved use, Off label use, Inappropriate schedule of product administration, Intentional dose omission, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, INFLIXIMAB, INFLIXIMAB, FINERENONE, |
||||
| 486 | 26912880 |
US |
2 | |
Malaise, Exposure during pregnancy, Therapy interrupted, |
||||
ASFOTASE ALFA, |
||||
| 487 | 26913236 |
CO |
70 | 2 |
Malaise, Rash, Pyrexia, Platelet count decreased, |
||||
VENETOCLAX, |
||||
| 488 | 26913310 |
US |
46 | 2 |
Decreased appetite, Migraine, Nausea, Abdominal pain upper, Malaise, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 489 | 26913317 |
US |
74 | 2 |
Malaise, Fall, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, |
||||
| 490 | 26913422 |
CA |
40 | 2 |
Pneumonia, Migraine, Depression, Dyspepsia, Systemic lupus erythematosus, Hepatitis, Back injury, Blister, Vomiting, Peripheral venous disease, Hypertension, Malaise, Osteoarthritis, Joint swelling, Coeliac disease, Abdominal distension, Bursitis, Hypercholesterolaemia, Taste disorder, Hypersensitivity, Rheumatic fever, Arthropathy, Contusion, Fibromyalgia, Injury, Dry mouth, Rheumatoid arthritis, Gait inability, Infusion related reaction, Nail disorder, Arthralgia, Dyspnoea, Insomnia, Drug hypersensitivity, Synovitis, Gastrointestinal disorder, Stomatitis, Helicobacter infection, Neck pain, Psoriatic arthropathy, Hypoaesthesia, Sleep disorder, Injection site reaction, Irritable bowel syndrome, Onychomadesis, Duodenal ulcer perforation, Pericarditis, Nasopharyngitis, Hand deformity, Pemphigus, Alopecia, |
||||
SECUKINUMAB, SECUKINUMAB, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, ERENUMAB-AOOE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ATOMOXETINE HYDROCHLORIDE, ETANERCEPT, ETANERCEPT, FOLIC ACID, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, MEPOLIZUMAB, TOFACITINIB, TOFACITINIB, AZATHIOPRINE, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, CANDESARTAN, CELECOXIB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CORTISONE ACETATE, |
||||
| 491 | 26913492 |
CA |
60 | 1 |
Asthma, Cough, Disease recurrence, Drug dependence, Dyspnoea, Eosinophil count increased, Eosinophilic granulomatosis with polyangiitis, Full blood count abnormal, Gastrooesophageal reflux disease, Haemoptysis, Hypoaesthesia, Malaise, Neuropathy peripheral, Paraesthesia, Productive cough, Upper respiratory tract infection, Vasculitis, Therapeutic product effect incomplete, |
||||
MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL SULFATE, AZATHIOPRINE, AZATHIOPRINE, AZATHIOPRINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, MOMETASONE FUROATE, BUDESONIDE, BUDESONIDE, BUDESONIDE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE, GLYCOPYRROLATE, MOMETASONE FUROATE, MOMETASONE, PREDNISONE, PREDNISONE, PREDNISONE, ROSUVASTATIN CALCIUM, TIOTROPIUM BROMIDE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 492 | 26913495 |
CL |
62 | 2 |
Blood pressure increased, Feeling abnormal, Fall, Anxiety, Epilepsy, Ankle fracture, Migraine, Bradycardia, Hypotension, Amnesia, Blood creatinine increased, Vomiting, Nausea, Hypertension, Diarrhoea, C-reactive protein abnormal, Blood urea abnormal, Blood cholesterol abnormal, International normalised ratio abnormal, Blood potassium abnormal, Insomnia, Foot fracture, Blood alkaline phosphatase increased, Dizziness, Haematocrit decreased, Haemoglobin decreased, White blood cell count decreased, Malaise, Headache, Abnormal behaviour, Emotional distress, Skin discolouration, Depression, Ligament sprain, Myopia, Contusion, Wound, Pain, Keratitis, Thrombosis, Metastases to bone, Loss of consciousness, Asphyxia, Choking, Petit mal epilepsy, Metastases to lung, Neoplasm malignant, Neutrophil count decreased, Tinnitus, Immunodeficiency, Eye swelling, Pulmonary pain, Depressed mood, Nasal ulcer, Noninfective gingivitis, Gingival erythema, Aphthous ulcer, Weight increased, Morton^s neuralgia, Hypoglycaemia, Food intolerance, Scab, Epistaxis, Nasal injury, Gait disturbance, Ageusia, Visual impairment, Musculoskeletal chest pain, General physical health deterioration, Electric shock sensation, Full blood count decreased, Influenza, Productive cough, Cough, Pharyngitis, Haemoptysis, Pain, Fluid retention, Fat tissue increased, Dry eye, Back pain, Abdominal discomfort, Diarrhoea, Fatigue, Headache, Dysgeusia, Memory impairment, Aversion, Blood sodium increased, Eye pain, Yawning, Eyelid margin crusting, Eye disorder, Swelling, Nervousness, Anisocytosis, Poikilocytosis, Polychromasia, Macrocytosis, Elliptocytosis, Discomfort, Atrioventricular block first degree, Red cell distribution width increased, Red blood cell sedimentation rate increased, Blood glucose increased, Gastrointestinal disorder, Mean cell volume increased, Rouleaux formation, Limb deformity, Oral herpes, Ill-defined disorder, Thyroid mass, Visual impairment, Decreased immune responsiveness, Neoplasm, Arthritis, Gingival disorder, Pruritus, Hypersensitivity, Pyrexia, Red blood cell count decreased, Lymphocyte count decreased, Dry skin, Pain in extremity, Vision blurred, Herpes virus infection, Viral diarrhoea, Colitis, Chills, Agitation, Confusional state, Oesophagitis, Gastrooesophageal reflux disease, Stress, Catheter site pain, High density lipoprotein abnormal, Gait inability, Mobility decreased, Diplopia, Impaired healing, Weight decreased, Nasopharyngitis, Alopecia, Tension headache, |
||||
LETROZOLE, LETROZOLE, LETROZOLE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, ANASTROZOLE, ANASTROZOLE TABLETS, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, LANSOPRAZOLE, ERGOCALCIFEROL, CALCIUM, |
||||
| 493 | 26913521 |
US |
45 | 1 |
Neuropathy peripheral, Insomnia, Fatigue, Depressed mood, Generalised oedema, Malaise, Product dose omission issue, |
||||
ACALABRUTINIB, |
||||
| 494 | 26913594 |
2 | ||
Abdominal pain upper, Abdominal pain, Malaise, |
||||
TIRZEPATIDE, |
||||
| 495 | 26913631 |
US |
||
Eye operation, Malaise, Memory impairment, Vomiting, Adverse reaction, |
||||
VUTRISIRAN, |
||||
| 496 | 26913650 |
GB |
67 | 1 |
Depression, Gastrooesophageal reflux disease, Drug interaction, Sleep disorder, Malaise, |
||||
CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, |
||||
| 497 | 26913676 |
US |
59 | |
Malaise, Abdominal discomfort, |
||||
| 498 | 26913744 |
65 | 2 | |
Hepatic function abnormal, White blood cell count decreased, Oropharyngeal pain, Malaise, |
||||
ABEMACICLIB, LETROZOLE, LETROZOLE TABLETS, |
||||
| 499 | 26913848 |
US |
77 | 2 |
Feeling cold, Malaise, |
||||
SIBEPRENLIMAB, |
||||
| 500 | 26913942 |
US |
1 | |
Product storage issue, Burning sensation, Product dose omission issue, Malaise, |
||||
ORAL SEMAGLUTIDE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30